Banbury Partners’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-197,258
Closed -$17.7M 16
2017
Q1
$17.7M Sell
197,258
-41,477
-17% -$3.57M 5% 14
2016
Q4
$20.6M Buy
238,735
+11,288
+5% +$1.01M 6.37% 7
2016
Q3
$19.7M Buy
227,447
+73,599
+48% +$7.39M 7.08% 7
2016
Q2
$16.4M Sell
153,848
-57,312
-27% -$5.91M 6.01% 11
2016
Q1
$22.3M Sell
211,160
-55,400
-21% -$5.31M 7.56% 6
2015
Q4
$23.7M Sell
266,560
-28,340
-10% -$2.53M 9.62% 3
2015
Q3
$26.7M Buy
294,900
+185,070
+169% +$18.5M 11.06% 5
2015
Q2
$11.7M Sell
109,830
-17,795
-14% -$1.78M 6.91% 9
2015
Q1
$11.8M Sell
127,625
-108,390
-46% -$9.36M 7.49% 8
2014
Q4
$20.6M Buy
+236,015
New +$19M 14.72% 2

Other funds holding CRI

Banbury Partners's CRI Position: Q2 2017 in Review

Banbury Partners sold out of Carter's (CRI) in Q2 2017, closing a stake of 197,258 shares — an estimated $17.7M sold.

Banbury Partners first reported a position in CRI in Q4 2014 and held it in 10 quarters. The position peaked at $26.7M in Q3 2015. 329 funds tracked by Wall St. Rank hold CRI as of Q2 2017.

  • Banbury Partners reported no remaining Carter's position as of Q2 2017 after selling out during the quarter.
  • Banbury Partners sold 197,258 Carter's shares in Q2 2017, an estimated $17.7M.
  • Banbury Partners first reported a position in Carter's in Q4 2014 and held it in 10 quarters.
  • Banbury Partners's Carter's position peaked at $26.7M in Q3 2015.
  • 329 funds tracked by Wall St. Rank held Carter's as of Q2 2017.

Based on Banbury Partners's 13F filing for Q2 2017, filed 14 Aug 2017.